TETON-PPF is a phase III study of the molecule Treprostinil for slowing the progression and reducing the symptoms of progressive pulmonary fibrosis.
You may receive the investigational molecule or a placebo. The treatment is administered by inhalation.
To participate, you must have received a diagnosis of progressive pulmonary fibrosis.
Clic here to access the official record from the National Library of Medicine for this study